RGI
MRNA icon

River Global Investors’s Moderna MRNA Stock Holding History

River Global Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,539
Closed -$377K – 180
2024
Q1 		$377K Sell
3,539
-37
-1% -$3.73K 0.09% 179
2023
Q4 		$356K Sell
3,576
-2,126
-37% -$179K 0.07% 208
2023
Q3 		$589K Sell
5,702
-268
-4% -$29.9K 0.14% 176
2023
Q2 		$725K Buy
+5,970
New +$796K 0.14% 162

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

River Global Investors's MRNA Position: Q2 2024 in Review

River Global Investors sold out of Moderna (MRNA) in Q2 2024, closing a stake of 3,539 shares — an estimated $377K sold.

River Global Investors first reported a position in MRNA in Q2 2023 and held it in 4 quarters. The position peaked at $725K in Q2 2023. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • River Global Investors reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • River Global Investors sold 3,539 Moderna shares in Q2 2024, an estimated $377K.
  • River Global Investors first reported a position in Moderna in Q2 2023 and held it in 4 quarters.
  • River Global Investors's Moderna position peaked at $725K in Q2 2023.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on River Global Investors's 13F filing for Q2 2024, filed 12 Aug 2024.